Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 61-70 of 76 for

Edit search filters
  1. Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma

    Rochester, MN

  2. Melanoma Relatlimab Nivolumab

    Jacksonville, FL, Rochester, MN

  3. A Study to Evaluate Immunotherapy and Ovarian Function Among Pre-menopausal Melanoma Survivors

    Rochester, MN

  4. A Study to Better Understand How to Predict and Manage Patients Who are at High Risk for Developing Rheumatic Immune-related Adverse Events While Receiving Treatment for Melanoma

    Rochester, MN

  5. Biomarkers to Predict for and Monitor Response to PD-1/PD-L1 Inhibitors

    Rochester, MN, Jacksonville, FL

  6. MElanoma Research Lymph node prediction Implementation National_001 (MERLIN_001)

    Rochester, MN

  7. Innovative CAR-TIL immunotherapy against melanoma

    Jacksonville, FL

  8. Molecular Characterization of Renal Cell Carcinomas and Melanomas

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. A Study of DNA Markers for the Detection of Metastatic Melanoma in Blood

    Rochester, MN

  10. Circulating Tumor Nucleic Acids to Monitor Treatment Response in Metastatic Melanoma Patients

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer